[Hemodynamic efficacy of modified gelatin in patients with acute blood loss and sepsis]
Related Experiment Video
Updated: Jun 9, 2026

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
Anesteziologiia I Reanimatologiia
|August 26, 2010
Abstract:
The paper presents the results of a clinical trial using the new modified gelatin-based drug hemofusin to correct dyshidria in patients with blood loss and sepsis. Based on the findings, the authors provide evidence for the high clinical efficacy of this drug and the expediency of its incorporation into a complex of infusion therapy in this patient contingent.

